Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07122583 · ClinicalTrials.gov registry record · Phase 4
A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the CoolSculpting Elite System
A Phase 4 study of Non-Surgical Fat Reduction, sponsored by AbbVie.
- Active
- Registry status
- Phase 4
- Development phase
- 102
- Enrollment target
- 1
- Study location
NCT07122583: Active Phase 4 study of Non-Surgical Fat Reduction, sponsored by AbbVie.
NCT07122583 is a Phase 4 study of Non-Surgical Fat Reduction that is active but no longer recruiting, run by AbbVie. The registered enrollment target is 102 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07122583, a Phase 4 study of Non-Surgical Fat Reduction, is active but no longer recruiting, sponsored by AbbVie.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this protocol is the continued collection of data specific to the submental, inner thigh and back/bra body areas with CoolSculpting Elite. The study aims to collect post-market safety data while allowing for the collection of standardized photos and satisfaction questionnaires after treatment with commercial treatment parameters.
Primary Outcome
Frequency of device and procedure-related AEs including serious device-related adverse events (SADEs), will be analyzed per cohort.
Conditions Studied
Interventions
- DEVICE CoolSculpting Elite System
Study Locations (1)
California
- Pacific Clinical Innovations - Vista
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2025-07-22 |
| Est. Completion | 2026-08 |
| Phase | Phase 4 |
What the registry record for NCT07122583 still lists
NCT07122583 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Non-Surgical Fat Reduction appearing as the primary indexed condition, and to 1 intervention - of which CoolSculpting Elite System is the first listed.
NCT07122583 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07122583 about?
NCT07122583 is a clinical study titled "A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the CoolSculpting Elite System". The primary objective of this protocol is the continued collection of data specific to the submental, inner thigh and back/bra body areas with CoolSculpting Elite. The study aims to collect post-market safety data while allowing for the collection of standardized photos and satisfaction questionnair...
What is the current status of trial NCT07122583?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 102 participants. The study started on 2025-07-22. Estimated completion is 2026-08.
What conditions does trial NCT07122583 study?
This clinical trial studies the following conditions: Non-Surgical Fat Reduction.
What interventions are being tested in trial NCT07122583?
The interventions under investigation include: CoolSculpting Elite System (DEVICE).
Who is sponsoring clinical trial NCT07122583?
This trial is sponsored by AbbVie, which has 526 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07122583 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07122583's enrollment target sits among peer trials
102 764th of 2000 higher than 1,236 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI